Global News Distribution

medicine

San Francisco Plastic Surgeon, Dr. Usha Rajagopal, Gives Newfound Confidence to Clients Undergoing FTM Surgery

January 31, 2022 (Global News Distribution) -

Using advanced laser technology, Dr. Usha Rajagopal helps boost confidence through the reduction of scarring due to surgeries, stretch marks, and a variety of skin conditions

San Francisco Plastic Surgery & Laser Center, a premier provider of plastic surgery services in the Bay Area for over 20 years, is giving clients renewed confidence with its powerful VBeam Laser technology. The VBeam Laser is effective for clients looking to reduce scarring due to a variety of reasons, but one application with especially promising results is reducing scarring following Female-to-Male (FTM) gender-affirming surgery. 

VBeam is one of the center’s most popular laser treatments. The FDA has approved it for use in over 20 medical indications, including post-procedural bruising, inflammatory acne, vascular lesions such as cherry angiomas and hemangiomas, spider veins, telangiectasia (commonly seen in rosacea), scars, stretch marks, port wine stains, and more.

The laser works by delivering a concentrated beam of light targeting oxyhemoglobin contained within blood vessels, vascular lesions, scars, and more. This light is then converted to heat, treating the targeted lesions while leaving the surrounding skin undamaged.

Dr. Usha Rajagopal, Medical Director, has successfully used the laser to reduce the appearance of scarring in the upper chest area for patients undergoing gender-affirming FTM/N surgery. The removal of breast tissue can lead to extensive scarring. But with VBeam technology, Dr. Rajgopal is helping patients reduce that scarring, leading to better post-surgery outcomes and giving patients an added boost of confidence in their new bodies. The treatments are quick, safe, and effective and require no anesthesia. 

“Every body is different, and the ways our scars heal are very different, too. For those who may be left with noticeable or unsightly scars, the effects on their confidence can be devastating,” said Dr. Rajgopal. “The VBeam laser is an effective solution to reduce the appearance of scarring in a number of instances, including FTM chest surgery, which leaves a long scar across the chest. With targeted VBeam treatment, we are helping patients enhance the look of their bodies and regain their confidence with the reduction of unsightly scarring.” 

To learn more about all of the services offered by San Francisco Plastic Surgery & Laser Center, including the VBeam laser, visit sfcosmeticsurgery.com.

CONTACT: Dr. Usha Rajagopal
PHONE: (415) 392-3333 
EMAIL: hello@sfcosmeticsurgery.com

Source: San Francisco Plastic Surgery & Laser Center

Media Contacts:


Full Name
Company
Phone Number
Website
Email

Compose your email to at .


  Spam Protection

The Canadian Regenerative Medicine Center for Wound Healing and Burns in Saudi Arabia

January 7, 2022 (Global News Distribution) -

The Canadian company, DCare Medical Supply – Canada, announced the signing of a joint memorandum of understanding between it and the Sarabeel Trading Corporation, “the Exclusive agent for the products of the Canadian company DCare in the Kingdom of Saudi Arabia and the Arabian Gulf countries ” to establish the largest specialized center that uses the modern technologies in tissue regenerative in the Kingdom of Saudi Arabia after obtaining the necessary approvals from the medical and the investment sectors in the Kingdom.

The center, which Carry the name of “The Canadian Regenerative Medicine Center for Chronic Wounds and Burns ” , is the first center in the Arab Gulf region that uses these modern technologies to save thousands of patients, “especially diabetics” from the specter of amputation of feet, as well as immunodeficiency patients, and the elderly, especially after major operations. who are exposed to chronic wounds that are difficult to heal and remain for years and pose a threat to their lives due to septicemia .

The center uses modern techniques to regenerate damaged tissues, whether with modern devices that stimulate the body to grow tissues instead of damaged ones. Some of these devices and products are registered with the Saudi Food and Drug Authority ” SFDA ” , such as Phoenix Wound Matrix devices, and others are manufactured as an alternative and substitute to the damaged skin through a specialized laboratory inside the center.

Dr. Ihab Tadros, the General Manager of the Canadian DCare Medical Company, says that , this specialized center will be managed by Canadian and Saudi medical staff trained in these modern techniques for tissue stimulation and skin transplantation, and it will be a point of contact with doctors and hospitals in the Kingdom of Saudi Arabia and Gulf region to provide its services to all doctors and professionals in the Gulf region . The center will also hold training seminars for those wishing to train in tissue regenerative medicine techniques. As well as those interested in medical research on this modern technology in cooperation with universities and research institutions in Canada, America and Europe.

The center will also receive patients from the Gulf Cooperation Council countries to provide these services.

It is planned to establish the center in the late second half of the 2022 after obtaining all permits and approvals from the concerned authorities in the Kingdom of Saudi Arabia to start providing treatment services to the public.

For more details, you can visit the website of DCare Medical – Canada
https://dcaremedical.ca/

Ihab Tadros
DCare Medical Supply ltd
+1 587-892-5692

Media Contacts:


Full Name
Company
Phone Number
Website
Email

Compose your email to at .


  Spam Protection

nuEra Announces the Grand Opening of Their Newest Dispensary in Aurora, IL

December 28, 2021 (Global News Distribution) -

nuEra Opens Its Sixth Dispensary in Illinois

 nuEra, one of Illinois’ only vertically integrated cannabis companies wholly owned and operated within Illinois, proudly announces the Grand Opening of its newest dispensary this Friday, Dec. 31, in Aurora, Illinois. Operating hours this week are 11 a.m.-4 p.m. with Grand Opening hours on Thursday and Friday to be 10 a.m.-9 p.m. nuEra Aurora is located at 1415 Corporate Blvd. right next to Chicago Premium Outlets Mall and 420 feet from Exit 119B, Farnsworth Rd. 

The Grand Opening event will include a ribbon-cutting ceremony attended by the Mayor of Aurora and other special guests. nuEra has completely renovated the location for a convenient, fun, and easy retail experience. nuEra Aurora will offer online pre-ordering for adults 21 and older and is technology-enabled with kiosks for quick ordering for walk-ins. Pre-orders can be made at nueracannabis.com/aurora-adult-use-menu/.

“We are excited to bring our nuEra-branded products to Aurora, including our High Times 2021 Cannabis Cup first-place product ‘Dubble Joint,'” said Jonah Rapino, nuEra’s Marketing Director. The dispensary will also have hundreds of other products available for customers 21+. “We are preparing an amazing menu with an incredible array of products from Illinois’ best producers — flower, cartridges, edibles, and more. There will be something for everyone, and our budtenders are ready to educate and assist,” he added.  

nuEra was a pioneer in the Illinois cannabis market and has been serving the Illinois medical cannabis community since 2015 with locations in Chicago, Urbana, and East Peoria, where many Illinois residents have already been patients and customers for years. It also operates two additional Adult-Use-only dispensaries in Pekin and Champaign, Illinois. 

The company added 22 new positions to prepare for the onset of Adult-Use sales at its new locations and generated a large number of construction and other ancillary jobs for work designing the store’s exterior and interior to safely accommodate customers. At this time, the organization is following COVID guidelines for IDPH. Customers are required to wear masks and must maintain proper social distancing while shopping in-store.

nuEra is also committed to giving back to the community in a variety of ways. Since full-legalization in January 2020, nuEra has been sourcing a majority of its staff from Disproportionately Impacted Areas (DIAs), hiring interns and apprentices from Cannabis Studies programs at City Colleges of Chicago and, whenever possible, partnering with minority- and women-owned businesses for ancillary services. Most recently, nuEra Hillcrest Cultivation recently donated $100,000 to Illinois Valley Community College’s cannabis production certificate program, and nuEra Dispensaries have donated over $370,000 to the Social Equity Cannabis Business Development Fund, which will be used to support new Social Equity Cannabis license holders in Illinois via low-interest loans and other programs. 

Find out more about nuEra at www.nueracannabis.com.

Media Contact
Jonah Rapino – Director of Marketing
jrapino@nueracannabis.com 
(773) 687-8480

Source: nuEra

Media Contacts:


Full Name
Company
Phone Number
Website
Email

Compose your email to at .


  Spam Protection

Turning Precision Medicine into Action in Immuno-Oncology, Upcoming Webinar Hosted by Xtalks

September 15, 2021 (Global News Distribution) -

In this free webinar, the featured speakers will discuss the benefits of ICH and flow cytometry in oncology drug development and how NGS testing for patient diagnostics is building databases for researchers. Attendees will learn how central and specialty laboratories can combine their efforts to meet the needs of immuno-oncology drug developers.

The challenges in immuno-oncology drug development require deep scientific insights, generation and analysis of complex biological data, new state-of-the art technologies and both logistical & operational support across continents. The goal of immuno-oncology drug developers is to turn precision medicine into action, bringing life-changing therapies to patients.

Immuno-oncology clinical trials have very low success rates, with just 5.3 percent of all drugs seeking an oncology indication eventually receiving approval. In the path to precision medicines, the use of molecular markers and protein biomarkers in both early- and late-stage immuno-oncology trials has become an increasingly important way to optimize patient selection, perform safety monitoring and measure drug efficacy at the tumor level. Immunohistochemistry (IHC), flow cytometry and next-generation sequencing (NGS) are complementary technologies that, together, offer comprehensive biological insights essential for immuno-oncology clinical trials.

Register for this webinar to learn why these technologies are essential to improve the odds of success in oncology drug development and how to find a central lab capable of developing customized assays with standardized SOPs across sites.

Join expert speakers from Cerba Research, Jérôme Sallette, Ph.D., Chief Scientific Officer, Cerba Healthcare; Sofie Vandevyver, Ph.D., Head of Business Operating and Marketing; Renaud Burrer, Ph.D., Head of Histopathology; and Nithianandan Selliah, Ph.D., Global Head of Flow Cytometry, as well as expert speakers from ACT Genomics, Shu Jen Chen, Ph.D., Chief Scientific Officer and George Wei, Ph.D., Vice President, R&D Division, in a live webinar with two broadcast dates on Monday, October 4, 2021 at 10am EDT (3pm BST/UK) and Tuesday, October 5, 2021 at 10am CST (China).

For more information, or to register for this event, visit Turning Precision Medicine into Action in Immuno-Oncology.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact Author

SYDNEY PERELMUTTER

Xtalks
+1 (416) 977-6555 x 352

Read More

Media Contacts:


Full Name
Company
Phone Number
Website
Email

Compose your email to at .


  Spam Protection

Dr. Carlos Barba Collaborates on the Second of Three New Articles

September 5, 2021 (Global News Distribution) -

The bariatric and general surgeon acted as an expert consultant on the second in a trilogy of informative new articles about issues surrounding bariatric surgery.

It is with much pride and pleasure that bariatric and general surgeon Dr. Carlos Barba of Brownsville, Texas announces that he has lent his medical expertise to the second of three new articles about important issues surrounding weight loss surgery. The article, which is entitled Failed Weight Loss Surgery? Dr. Carlos A. Barba Explains Potential Issues Derailing Bariatric Surgery Success, was published on August 9, 2021, and was written in conjunction with an online periodical that runs news and opinion pieces from all around the United States.

At the outset of the article, Dr. Barba does not mince words about the primary reason that some bariatric surgeries do not provide lasting results. “One of the main reasons weight loss surgery fails to be effective is the regression to previous lifestyle choices,” he writes, going to explain that patients undergoing such surgeries are given explicit instructions about food intake, exercise, and personal mindset with relation to their body image. “For weight loss surgery to be successful and for results to last, the individual must also have a personal lifestyle change. Gradual poor choices compound over time, leading to weight gain compared to one’s pre-surgery condition.”

Later on in the piece, Dr. Carlos Barba delves deeper into standard post-operation instructions given to patients of bariatric surgery, explaining, “After weight loss operation procedures, internal organs are still healing and may need time to get used to processing foods and performing daily functions.” He then proceeds to outline how not abiding by doctor’s orders regarding eating slowly and mindfully, avoiding certain foods, and drinking in between meals can be medically dangerous for patients, as well as causing them to regain unwanted weight.

The full text of the article can be found here.

For those curious to learn more about Dr. Carlos Barba, his blog posts, press clippings, and a host of other multimedia content relating to his career can be found on his personal website. Anyone interested in booking an appointment to consult with Dr. Barba regarding medical issues or to read news and updates relating to his practice are encouraged to visit his professional website.

About Dr. Carlos Barba:

Dr. Carlos Barba is a bariatric and general surgeon with medical practices in the towns of Brownsville and Harlingen, Texas. After graduating from the University of Montreal and the University of Pennsylvania, he finished his medical training by completing a fellowship in trauma and critical care. Upon moving to Hartford, Connecticut, Dr. Barba began performing bariatric surgery due to the high demand for it in the area coupled with the lack of local qualified surgeons in that specialty. He quickly became a member of the American Society of Metabolic and Bariatric Surgeons (ASMBS), and in 2005, became involved in creating Connecticut’s first ASMBS Center of Excellence. When Dr. Barba relocated to Texas in 2013, he created the first ASMBS Center of Excellence in the Rio Grande Valley, located in Cameron Country. To garner this designation, both the surgeon and the medical center in question have to meet the highest standards for patient care. These days, Dr. Carlos Barba spends about half his professional time on bariatric surgery and the other half on general surgery.

Contact Information:

Dr. Carlos Barba
800 West Jefferson Street, #100
Brownsville, Texas 78250
Phone: (956) 621-4981
Professional Website: carlosabarbamd.com
Personal Website: carlosabarba.com

SOURCE: Dr. Carlos Barba

Media Contacts:


Full Name
Company
Phone Number
Website
Email

Compose your email to at .


  Spam Protection

Innovative Healthcare Solutions Provider ‘Health Karma’ Reports Many Accomplishments To Date This Year

August 25, 2021 (Global News Distribution) -

MediXall Group, Inc. (OTCQB: MDXL), a leading innovative healthcare solutions provider, today provided an update on the growth and accomplishments of its wholly-owned subsidiary, Health Karma™ this year. To date, 2021 has been very positive for Health Karma, with the company accomplishing the following:

  • Appointed Experienced Health Insurance Technology Executive Travis Jackson as New Chief Executive Officer of Health Karma. Mr. Jackson brings a wealth of experience across virtually every dimension of healthcare. He is a seasoned leader with significant experience driving revenue growth in health insurance and health tech market segments, operating efficiently at scale, and delivering value to shareholders.
  • Launched In the mid-first quarter Virtual Primary Care + Behavioral Health (VPC + BH) offering to employers, with it now having a growing list of employers offering Health Karma VPC as part of their employees benefits packages.
  • Launched Partner Program also in the late first quarter to provide additional multi-tiered sales channels to deliver product offerings to employers and individuals. Health Karma continually adds new partners each week adding to the force of insurance brokers, agencies, associations, and other organizations/individuals offering Health Karma to their client base.
  • Added nearly 200 reps selling Health Karma in our Partner Program and the number continues growing each week.
  • Created on the consumer side a scalable acquisition channel now being ramped up and starting to drive direct to consumer sales.
  • Hired leading PR Firm, TransMedia Group, to drive brand awareness & media relations to propel Health Karma on its next phase of growth. The PR campaign will focus on Health Karma’s success as it enters the next phase of growth and seeks to expand its footprint on healthcare. The award-winning PR firm will help the company improve its corporate messaging and enhance communications with key stakeholders.
  • Gained recognition for its thought leadership in virtual care from traction generated from Health Karma’s VPC + BH offering.
  • Published in CEOWorld Magazine was President of Health Karma, Michael Swartz’s article entitled “How Employers Can Support Remote Workers With Telehealth Options,” which got 12.4+ million page views, CEOWORLD magazine is a leading business magazine written strictly for CEOs, CFOs, CIOs, senior management executives, business leaders, and high net worth individuals worldwide.
  • Michael Swartz was also featured in Authority Magazine’s thought leadership interview series called “5 Things We Must Do to Improve the U.S. Healthcare System“. Since 2018, Authority Magazine has conducted more than 25,000 interviews with prominent Authorities like Ava DuVernay, Chris Evans, Shaquille O’Neal, Peyton Manning, and the C-Suite executives of companies like eBay, Kroger, American Express, Bank of America, Google, Twitter, Spotify, and thousands of others.
  • Sparking Health Karma’s momentum and growth, Michael Swartz was selected as an honoree for the First Annual South Florida Business & Wealth (SFBW) Excellence in Healthcare Awards in the Rising Star (40 & under) category.

Commenting on the company’s accomplishments this year, Health Karma Chief Executive Officer, Travis Jackson said “The Company’s current momentum and growth is a testament to Michael & the entire Health Karma team’s incredible efforts building Health Karma™ – their passion for our members, and tireless drive to transform the healthcare experience, has better positioned us to capture the many great opportunities that lie ahead. I look forward to leading the company to new heights through the rest of 2021 and beyond.”

For more information on Health Karma, visit their official website: www.healthkarma.org and follow @HealthKarmaApp on Facebook, Instagram, and Twitter.

About MediXall Group, Inc.

MediXall Group, Inc. (OTCQB: MDXL) is a technology and innovation-driven organization purposefully designed and structured around delivering products and services to make it easier for consumers to learn, decide and pay for healthcare. The mission of MediXall Group is to revolutionize the healthcare industry by improving communication; providing better technology and support services; and enabling more efficient, cost-effective healthcare for the consumer. By approaching the entire healthcare ecosystem, MediXall creates, invests, and incubates companies that embody its mission statement.

About Health Karma, Inc.

Health Karma, a wholly-owned subsidiary of MediXall Group, is a data-driven healthcare technology company whose mission is to continually raise the bar of the healthcare experience by empowering people to understand and manage their entire health care journey anywhere, anytime, whether they have insurance or not. For more information, please visit www.gethealthkarma.com.

Media Contact: Karla Hernandez, karlahernandez.transmediagroup@gmail.com, 561-768-1773.

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company’s current plans and expectations, as well as future results of operations and financial condition. Specifically, the company’s ability to raise additional capital, execute its business plan and strategy, sustain, or increase gross margins, achieve profitability, and build shareholder value are forward-looking statements. A more extensive listing of risks and factors that may affect the company’s business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact:

Investor Relations
(954) 653-8216

SOURCE: MediXall Group, Inc.

Media Contacts:


Full Name
Company
Phone Number
Website
Email

Compose your email to at .


  Spam Protection

The Lung Health Foundation Contracts with Cloud DX to Manage Chronic Obstructive Pulmonary Disease with Remote Patient Monitoring

June 28, 2021 (Global News Distribution) -

Cloud DX (TSXV:CDX), a leading North American provider of virtual care and remote patient monitoring solutions announced today a new partnership with the Lung Health Foundation to supply remote patient monitoring (RPM) kits and services in the Province of Ontario. The Lung Health Foundation intends to deploy Cloud DX Connected Health through Ontario-based hospital partners to improve care for patients suffering from chronic obstructive pulmonary disease (COPD).

his announcement is the latest in a series of contracts announced by Cloud DX in recent weeks, including a contract extension with a large Canadian provincial health authority, a partnership agreement with US-based Maxwell Telecare and a virtual clinic deployment in Newfoundland.

According to Canadian Institute of Health Information, over 23,000 Ontarians are admitted to hospital every year for COPD. Each hospital stay lasts an average of 5.6 days at an average cost to the province of $6,200 per visit or $142 million per year, making COPD exacerbation one of the largest healthcare costs in Ontario.

Cloud DX’s remote patient monitoring platform is used by healthcare providers to improve COPD patient outcomes, with deployments at Markham Stouffville Hospital, Hamilton Health Sciences and Kingston Health Sciences Centre among others. Remote monitoring by Cloud DX helps clinicians detect symptoms of COPD exacerbation earlier, and trigger pre-approved action plans to guide COPD patients to take immediate steps to alleviate their symptoms, reducing ER visits and hospitalizations. The result is better healthcare outcomes for patients and lower COPD hospital costs.

This 12-month contract can be renewed by Lung Health or any of the participating healthcare partners at the completion of the initial term. Cloud DX charges upfront for Connected Health Kits that are prescribed to patients for use at home, and then charges a per patient per month fee for software, services and support as each patient enrolls in the Connected Health system. In this case, all fees are paid by Lung Health.

“The COVID-19 pandemic underscored the vulnerability of individuals with COPD. Remote patient monitoring has been shown to be beneficial in helping predict exacerbations while providing patients with critical information required to manage their own condition. Early intervention and better disease management improves quality of life and lowers healthcare resource utilization. Private-public partnerships such as the one between our two organizations are key to getting at the core of some of the healthcare challenges we’ve long been facing,” says Peter Glazier, Executive Vice President of the Lung Health Foundation.

“Cloud DX Connected Health has been shown to be a powerful tool to mitigate the impact of COPD, improving the lives of patients while at the same time streamlining provider workflows. We’re proud to be a partner with the Lung Health Foundation to expand the number of Ontarians that have access to this life-changing technology,” stated Cloud DX CEO Robert Kaul.

About the Lung Health Foundation

The Lung Health Foundation is the leading Canadian health charity dedicated to improving lung health through a uniquely integrated approach that identifies gaps and fills them through investments in ground-breaking research and urgently needed programs and supports, policy and practice change, and promoting awareness about lung health issues affecting all Canadians.

About Cloud DX

Accelerating virtual healthcare’s future, Cloud DX is making healthcare better for everyone. The company’s Connected Health remote patient monitoring platform is used by healthcare enterprises and care teams across North America to virtually manage chronic disease, enable ageing in place and deliver hospital-quality post-surgical care. Providers partnering with Cloud DX achieve better healthcare and patient outcomes, reduce the need for hospitalization/re-hospitalization and reduce the costs of healthcare delivery through more efficient use of resources. Cloud DX is the co-winner of the Qualcomm Tricorder XPRIZE, a 2021 Edison Award winner, a Fast Company “World Changing Idea” finalist and one of “Canada’s Ten Most Prominent Telehealth Providers.”

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this release.

Social Links

Twitter: https://twitter.com/CloudDX

Facebook https://www.facebook.com/clouddxinc/

LinkedIn https://www.linkedin.com/company/cloud-dx/

Instagram https://www.instagram.com/cloud.dx/

For media inquiries please contact:

Ellyn Winters-Robinson
Ignition Communications (PR for Cloud DX)
519-574-2196
ellyn@ignition.ca

For investor inquiries please contact:

Jay Bedard
Cloud DX Investor Relations
647-881-8418
jay.bedard@CloudDX.com

SOURCE: Cloud DX Inc.

Media Contacts:


Full Name
Company
Phone Number
Website
Email

Compose your email to at .


  Spam Protection

DiaspoCare is Providing Peace of Mind For The Health of Your Loved Ones With its Healthcare Inclusion Platform

June 18, 2021 (Global News Distribution) -

Serge-Alain Wandji is the CEO and Co-Founder of DiaspoCare.com , a startup whose mission is to increase healthcare inclusion in developing countries. The mobile platform provides new opportunities to connect the African Diaspora to pharmacists and clinicians back home while also giving African sponsors in the Western Hemisphere the opportunity to deliver quality healthcare to their loved ones.

Whether separated by thousands of miles or living in another city, DiaspoCare’s healthcare financing services give families peace of mind that their funds deliver quality healthcare for their loved ones. The platform works through partnerships with healthcare providers, like pharmacies, where medical expenses are channeled directly to the service providers in their home country while tracking transactions and protecting privacy.

“I was born and raised in Cameroon, Africa. My parents depleted their savings to send me to college in North America when I was 18 years old. I settled my due with my father by completing a PhD, postdoctoral work in biomedical research and a Master’s degree in management of technology. However, like many African immigrants know, you settle your dues with your mother by helping others. We started DiaspoCare seven years ago because, as African immigrants, we have a strong moral obligation to help our loved ones back home. When you look at healthcare in many developing countries, 12 of the most prescribed medicines cost 5-50x the international price. Low-income earners often spend 93% of their income on housing, food, transportation and utilities, leaving only 7% for medicines. It would take them as much as 14-days wage to afford one course of some essential medicines. So, it’s not surprising that the lack of affordability leaves two-thirds of the people living in Africa out of the healthcare system,” explains CEO and Co-Founder of DiaspoCare, Serge-Alain Wandji.

He goes on to say, “The African diaspora takes its social obligations seriously and, as reported by the World Bank in 2019, transferred around $48Bn to their families in home countries to help with healthcare, food, utility bills, and other expenses. The problem is that healthcare funds are frequently diverted to other uses and not enough medicine is bought, if any at all.

When we created this platform, we wanted to find a way to unbundle the portion of remittances meant for healthcare and send it directly to a network of trusted pharmacies and clinics while also ensuring the delivery of quality medication and healthcare services to family members and loved ones. In the past, without knowing the cost of medicines, we would take a guess and send say, $50-$100 when solicited by a family member. Given the number of relatives who depend on us, it can be quite a lot of money. By providing price transparency and enabling micro-payments directly to pharmacies, DiaspoCare makes it practical to cover even your remote relative’s $2 malaria prescription. Also, our transaction fees are less than 3% and we are working toward completely eliminating them. So we stretch every healthcare dollar invested on our platform to touch many more lives. These efforts are significant steps towards healthcare inclusion.

Register as a sponsor on our mobile app. When your family needs medication or clinical services, all you need to do is make the payment from the app directly to the Pharmacy or Clinic and your loved ones will be taken care of.”

The DiaspoCare system is not only helping families, but it’s also helping Pharmacists earn new revenues from global customers. “Naturally, when we came to pharmacists with the idea, they loved it. Before we even built our platform, they were signing up for our program.”

“DiaspoCare is an opportunity for us to not only finance healthcare for many people who can’t afford it but also to ensure they actually get quality medicines.”

The DiaspoCare project is deployed in Kenya and Ghana, and piloting in Nigeria and Cote-d’Ivoire, with 240 pharmacies. Some partners include GoodLife Pharmacy, which is private-equity funded and the largest pharmacy chain in Kenya, two major hospitals, Jubilee Health Insurance, the largest health insurance company in East Africa and Ecobank, the largest bank in Africa. The venture is led by a brilliant team of highly skilled professionals who have a strong moral and social obligation to help their loved ones back home with their healthcare needs. For more information on DiaspoCare, visit www.diaspocare.com.

Company Name: DiaspoCare
Contact Person: Serge-Alain Wandji
Address: 2147 University Avenue West, Suite 105, St. Paul, MN 55114
Phone Number: +1 612 444 9876
Website Links: http://www.diaspocare.com/ 
App:
https://play.google.com/store/apps/details?id=com.diaspocare.android&hl=en_US&gl=US 
https://apps.apple.com/us/app/diaspocare/id1470632234 

SOURCE: DiaspoCare

Media Contacts:


Full Name
Company
Phone Number
Website
Email

Compose your email to at .


  Spam Protection

Americans Hunt for Certified Canadian Online Pharmacies to Avoid Rogue Pharmacies

May 19, 2021 (Global News Distribution) -

It’s always important to make an informed decision where you get your medication. While convenient, many online pharmacies are considered “Rogue pharmacies” that may not provide safe and effective medication.

Your Canada Drug Store has 20 years of combined experience in the online pharmacy industry. They work hard to ensure that safe and effective medication can be affordable for the people that need it. They provide these tips to ensure that you are working with a legitimate and trustworthy online pharmacy.

1: Make sure it approved by CIPA and Pharmacychecker

Objective Third-party organizations are important to ensure you’re getting objective information about companies. CIPA and pharmacy checkers monitor online pharmacies to ensure that they comply with all the rules and regulations of the industry. A seal of approval by BOTH of these companies will ensure that you are working with a quality website.

2: Never order from a pharmacy that does not require a prescription.

Selling prescription drugs without a medical prescription is illegal. While it is sometimes difficult or costly to see a doctor, it is a prerequisite to find a legitimate source of the medication. If an online pharmacy is willing to send a medication without the proper documents, they will likely not follow safety guidelines or send a quality product.

While it may be tempting to take the easy route, your pharmacy should do its best to protect your health. If a website follows the proper guidelines of an online pharmacy, that is a good sign they are trustworthy.

3: Check that the website has encryption technology to protect your information.

While this may not be obvious to most people, website security should be a major concern. You likely need to provide personal, medical, and financial information to the website. While there are indications on the URL, they should provide their web severity credentials prominently on the front page. SSL encryption is the standard. You should also check the website’s privacy policy to ensure that they specify their personal information policy.

4: Ensure they have a pharmacist available for counseling

While many individuals are well educated on how to take their medicine, always check to make sure you can speak to a pharmacist when necessary. Online pharmacies have an obligation to ensure patients can use their medication properly and are cognizant of any potential risks. A website that will offer a medication without a licensed pharmacist on staff is likely willing to compromise your health.

5: Only order from a website that indicates where the medicine comes from

Most online pharmacies offer medication from around the world. Some individuals have preferences on where their medication comes from. Products from Canada and the U.K are often preferred even if they cost more.

There can be affordable and safe options from India and Turkey. Even if you do not have a specific preference in favor of the best prices, make sure that you are at least aware of where your products are dispensed from.

Pharmacies that are not transparent about this may be sourcing counterfeit medication from other countries. When an online pharmacy includes the country of origin, it confirms they have a relationship with that pharmacy and they are a reliable source of medication.

A website that does not properly evaluate its dispensing pharmacy partners may get their medicine from regulated supply chains. It may not be safe or effective.

6: Look at the reviews online

Customer reviews are a prediction of your potential experience with those companies. Everyone’s opinion should matter.

Companies that do not have a third-party review service may be trying to hide something. A successful and customer-focused Prescription drugs company should have mostly 5-staMedia Contactr reviews. People provide reviews of their own volition and as long as an objective third party service is hosting the review, they can work to inform you if people are happy using a service.

7: Make sure they guarantee their products

Even if you have taken painstaking care in choosing an online pharmacy, sometimes mistakes can happen. Occasionally things may get lost in the mail, or someone may make a mistake. When these things happen, the pharmacy should have a robust return policy or money-back guarantee. Online pharmacies that do not have a return guarantee do not trust their products and will not assist you when something happens that is out of your control. You should not take a risk when you order medicine online. Always review the website’s return policy to ensure they are reliable.

Finding a pharmacy that is genuinely concerned about your safety and well-being. According to the CDC, 1 in 10 Americans needs to ration their medicine and skip doses due to high drug costs. Once you have established a relationship with a professional online pharmacy, it should help manage your therapeutic drug plan.

Media Contact

Your Canada Drug Store
info@ycdscc.com
1-844-416-4282
https://ycdscc.com/

Media Contacts:


Full Name
Company
Phone Number
Website
Email

Compose your email to at .


  Spam Protection

Medicaid Expansion: How We Bounce Back

May 8, 2021 (Global News Distribution) -

This week, Wisconsin’s budget committee voted – yet again – to turn down the opportunity to expand the state’s Medicaid program, thereby eliminating the opportunity to provide health care and long-term care services for more Wisconsinites and declining more than $1.6 billion in federal funding. The $1.6 billion in new federal resources is the best way to bolster our health system and help Wisconsin bounce back by investing in the people of our state, their businesses, their families, their health care providers, and their health.

People across Wisconsin need the health care, nursing home care, home care, and more that the Medicaid program provides. And as taxpayers, they deserve to have their fair share of federal tax dollars returned to Wisconsin to pay for these important services. A total of 38 states have adopted Medicaid expansion, plus Washington, D.C. We are one of only 12 states that has not. By staying on the sidelines, we are all losing out on significant resources.

By moving ahead to expand Medicaid, we will see real impact on real lives.

Melissa, a small business owner, will feel more secure knowing her employees are able to access affordable health care coverage.

Andy, a Wisconsin resident with cerebral palsy, will get better care because the caregivers who make it possible for him to live and work at home will be able to take on more hours without worrying about going over the income limits and losing their BadgerCare Plus coverage.

Zena, who lives with a chronic illness caused by a norovirus infection, could pick up more hours at work and maintain her BadgerCare Plus coverage, including coverage for the only medication suitable to treat her condition. There is no generic alternative, and this single prescription costs $6,000 each month.

Covering more Wisconsinites and drawing down more federal funds through Medicaid expansion will support our health care and long-term care providers. Wisconsin could increase payment rates to hospitals, doctors, mental health therapists, and nursing homes. As more people gain coverage, providers also have fewer patients for whom no payment is available.

Taking steps to improve the health of low-income families and individuals, and the financial solvency of our health care system, will strengthen our state’s economy and enable us to bounce back faster. And accepting $1.6 billion in federal funding – our fair share of the taxes people have paid, and will continue to pay into the system – will provide Wisconsin the opportunity to make far-reaching investments in our state.

Past legislatures and our past Governor decided not to step up to the plate and make this common-sense change to our state’s Medicaid program. Those short-sighted decisions have left hundreds of millions of our tax dollars in Washington and made it harder for tens of thousands of Wisconsinites to access the health care they and their families need. We can’t turn back the clock and recoup that funding, but we can make a different decision going forward. We can expand Medicaid, improve the health and well-being of our fellow Wisconsinites, invest in our state, and help Wisconsin bounce back.

Media Contacts:


Full Name
Company
Phone Number
Website
Email

Compose your email to at .


  Spam Protection